ストックスクリーナーアプリを入手
114.41
1.68%
-2.36
前日終値:
$116.77
開ける：
$116.35
24時間の取引高:
78,703
Relative Volume:
0.06
時価総額：
$9.05B
収益：
-
当期純損益:
$-159.39M
株価収益率:
-32.32
EPS:
-3.5401
ネットキャッシュフロー:
$-105.22M
1週間 パフォーマンス:
-3.90%
1か月 パフォーマンス:
+3.70%
6か月 パフォーマンス:
+30.42%
1年 パフォーマンス:
+1,363%
1日の値動き範囲:
$114.50
$116.45
1週間の範囲:
$105.78
$122.49
52週間の値動き範囲:
$4.77
$148.83
Abivax Adr Stock (ABVX) Company Profile
Compare ABVX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
114.50 | 9.23B | 0 | -159.39M | -105.22M | -3.5401 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.94 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
774.57 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
730.65 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.71 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
295.05 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-24 | 開始されました | Truist | Buy |
| 2025-11-06 | 開始されました | Wolfe Research | Outperform |
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-07-23 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-03-20 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-12-04 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-07-29 | 開始されました | Laidlaw | Buy |
| 2024-05-20 | 開始されました | BTIG Research | Buy |
| 2024-04-29 | 開始されました | Guggenheim | Buy |
| 2024-04-29 | 開始されました | Piper Sandler | Overweight |
| 2023-11-14 | 開始されました | Leerink Partners | Outperform |
| 2023-11-14 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Abivax Adr (ABVX) 最新ニュース
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
TD Asset Management Inc Buys New Shares in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Down 13.2% in February - MarketBeat
Erste Asset Management GmbH Buys New Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Envestnet Asset Management Inc. Acquires New Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Optiver Holding B.V. Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Irhythm Technologies (IRTC) - The Globe and Mail
Greenland Capital Management LP Purchases Shares of 25,039 Abivax SA Sponsored ADR $ABVX - MarketBeat
Patient Square Capital LP Purchases Shares of 151,833 Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 - GlobeNewswire Inc.
Persistent Asset Partners Ltd Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
TimesSquare Capital Management LLC Takes $10.87 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Aberdeen Group plc Has $66.85 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
ABIVAX Societe Anonyme (ABVX): A Bull Case Theory - Finviz
Federated Hermes Inc. Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
ABIVAX Societe Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs - Finviz
Nan Fung Trinity HK Ltd. Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Privium Fund Management B.V. Makes New $2.58 Million Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), Ascendis Pharma (ASND) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's What You Should Know - MSN
Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Up 25.0% in December - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Abivax SA Sponsored ADR (ABVX) Receives a Buy from Truist Financial - The Globe and Mail
Why Abivax SA Sponsored ADR Shares Are Surging - TipRanks
FY2025 EPS Estimates for Abivax Reduced by Lifesci Capital - Defense World
ABIVAX Societe Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly - Finviz
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Is ABIVAX Societe Anonyme (ABVX) One of the Hottest Large-Cap Stocks of 2025? - Finviz
Could This Potential Move Boost Eli Lilly's Prospects? - Finviz
Voya Investment Management LLC Invests $978,000 in Abivax SA Sponsored ADR $ABVX - MarketBeat
61,449 Shares in Abivax SA Sponsored ADR $ABVX Purchased by Simplify Asset Management Inc. - MarketBeat
Abivax (NASDAQ:ABVX) Shares Gap UpHere's What Happened - MarketBeat
Guggenheim Bullish on Abivax (ABVX) Ahead of Key Obefazimod Data Readout - Finviz
Abivax (NASDAQ:ABVX) Trading Up 6%Time to Buy? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Integra Lifesciences (IART) - The Globe and Mail
Abivax (NASDAQ:ABVX) Sets New 1-Year HighHere's Why - MarketBeat
Why Abivax Stock Was on Fire Today - Finviz
Why Abivax SA Sponsored ADR Shares Are Tumbling - TipRanks
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Abivax shares gain after 22 scientific abstracts accepted for ECCO 2026 - MSN
Abivax stock rises after announcing acceptance of 22 abstracts at ECCO 2026 - Investing.com
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Novan (NOVN) - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Citizens Jmp Issues Positive Forecast for Abivax (NASDAQ:ABVX) Stock Price - Defense World
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers - ts2.tech
Abivax (NASDAQ:ABVX) Trading Down 5.9%Should You Sell? - MarketBeat
Abivax SA Reports Increased Losses in Q3 2025 Amid Rising R&D Costs - The Globe and Mail
Abivax SA reports increased losses in Q3 2025 amid rising R&D costs - MSN
FY2025 EPS Estimates for Abivax Decreased by Lifesci Capital - MarketBeat
Abivax Adr (ABVX) 財務データ
収益
当期純利益
現金流量
EPS
0.50%
大文字化:
|
ボリューム (24 時間):